Table 4 The occurrence of adverse events in patients with CAD during one year follow-up
End point | CC(204) | CT(163) | TT(30) | P value |
|---|---|---|---|---|
Death, n (%) | 2(1.0) | 1(0.6) | 1(3.3) | 0.39 |
refractory angina, n (%) | 1(0.5) | 3(1.8) | 2(6.7) | 0.032* |
MI, n (%) | 2(1.0) | 2(1.2) | 1(3.3) | 0.558 |
TVR, n (%) | 1(0.5) | 2(1.2) | 1(3.3) | 0.324 |
cerebrovascular events, n (%) | 4(2.0) | 3(1.8) | 1(3.3) | 0.864 |
MACE, n (%) | 10(4.9) | 11(6.7) | 6(20.0) | 0.009* |